EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

N-acetylcysteine Pharmacology and Applications in Rare Diseases—Repurposing an Old Antioxidant

Siddhee A Sahasrabudhe iD, Marcia R Terluk, Reena V Kartha iD

Antioxidants · 21.06.2023 · 12 (7) · 1316

DOI: 10.3390/antiox12071316 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 21.06.2023. Verfasst von Siddhee A Sahasrabudhe und 2 weiteren Autor:innen. Beteiligte Einrichtung: Center for Orphan Drug Research, Department of Experimental and Clinical Pharmacology, Rm 4-214, McGuire Translational Research Facility, 2001 6th St…. Die Arbeit wurde bisher 103-mal zitiert (Crossref) und nennt 163 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

N-acetylcysteine (NAC), a precursor of cysteine and, thereby, glutathione (GSH), acts as an antioxidant through a variety of mechanisms, including oxidant scavenging, GSH replenishment, antioxidant signaling, etc. Owing to the variety of proposed targets, NAC has a long history of use as a prescription product and in wide-ranging applications that are off-label as an over-the-counter (OTC) product. Despite its discovery in the early 1960s and its development for various indications, systematic clinical pharmacology explorations of NAC pharmacokinetics (PK), pharmacodynamic targets, drug interactions, and dose-ranging are sorely limited. Although there are anecdotal instances of NAC benefits in a variety of diseases, a comprehensive review of the use of NAC in rare diseases does not exist. In this review, we attempt to summarize the existing literature focused on NAC explorations in rare diseases targeting mitochondrial dysfunction along with the history of NAC usage, approved indications, mechanisms of action, safety, and PK characterization. Further, we introduce the research currently underway on other structural derivatives of NAC and acknowledge the continuum of efforts through pre-clinical and clinical research to facilitate further therapeutic development of NAC or its derivatives for rare diseases.

Schlagwörter

Stichwörter der Autor:innen

antioxidantmechanism of actionpharmacologyrare diseasesrepurposing

Autor:innen und Institutionen

  • Center for Orphan Drug Research, Department of Experimental and Clinical Pharmacology, Rm 4-214, McGuire Translational Research Facility, 2001 6th St. SE, College of Pharmacy, University of Minnesota, Minneapolis, MN 55…

ORCID-Profile: Siddhee A Sahasrabudhe, Reena V Kartha

Zitieren

APA

Sahasrabudhe, S. A., Terluk, M. R., & Kartha, R. V. (2023). N-acetylcysteine Pharmacology and Applications in Rare Diseases—Repurposing an Old Antioxidant. Antioxidants, 12(7), 1316. https://doi.org/10.3390/antiox12071316

Vancouver

Sahasrabudhe SA, Terluk MR, Kartha RV. N-acetylcysteine Pharmacology and Applications in Rare Diseases—Repurposing an Old Antioxidant. Antioxidants. 2023;12(7):1316. doi:10.3390/antiox12071316

BibTeX
@article{Sahasrabudhe2023,
  author = {Sahasrabudhe, Siddhee A and Terluk, Marcia R and Kartha, Reena V},
  title = {N-acetylcysteine Pharmacology and Applications in Rare Diseases—Repurposing an Old Antioxidant},
  journal = {Antioxidants},
  year = {2023},
  volume = {12},
  number = {7},
  pages = {1316},
  doi = {10.3390/antiox12071316}
}
Kostenlos starten →